Montelukast Farmax (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This inhibition prevents leukotrienes from causing bronchoconstriction, mucus production, and airway inflammation, thereby improving breathing and reducing allergic symptoms.

The appropriate dose of Montelukast Farmax is determined by the prescribing healthcare professional based on the patient’s age, condition, and clinical response. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for Montelukast during pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Healthcare providers should weigh potential benefits against risks before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids and long‑acting beta‑agonists. It is particularly useful for patients with aspirin‑exacerbated respiratory disease or those who need an add‑on therapy, but it does not replace rescue inhalers for acute attacks.

Montelukast Farmax should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Montelukast Farmax is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed.

Serious risks include rare allergic reactions such as angioedema or anaphylaxis, mood changes including suicidal thoughts, and rare severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelukast Farmax should be avoided in individuals with known hypersensitivity to montelukast or any of its excipients. It is not intended for acute asthma attacks and should not replace rescue bronchodilators in emergency situations.